SEGMENTED INFORMATION (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
REVENUE	$ 2,381,851	$ 2,377,205
COST OF REVENUE	(2,016,820)	(2,008,308)
GROSS PROFIT	365,031	368,897
OTHER INCOME	201,847	117,344
General and administrative	(645,906)	(536,872)
(LOSS)/PROFIT FROM OPERATIONS	(79,028)	(50,631)
FINANCE COSTS	(4,661)	(2,445)
(LOSS)/PROFIT BEFORE TAX	(83,689)	(53,076)
Tax expense	(20,068)	(15,990)
NET (LOSS)/PROFIT	(103,757)	(69,066)
GROSS PROFIT	365,031	368,897
NET LOSS	(103,757)	(69,066)
MRNA Scientific Malaysia [Member]
REVENUE	3,165	7,436
COST OF REVENUE	(2,252)	(5,347)
GROSS PROFIT	913	2,089
OTHER INCOME	38,694	1,126
General and administrative	(80,855)	(46,255)
(LOSS)/PROFIT FROM OPERATIONS	(41,248)	(43,040)
FINANCE COSTS	(1,950)	(666)
(LOSS)/PROFIT BEFORE TAX	(43,198)	43,706
Tax expense	0	0
NET (LOSS)/PROFIT	(43,198)	(43,706)
GROSS PROFIT	913	2,089
NET LOSS	(43,198)	(43,706)
Chemrex [Member]
REVENUE	2,378,686	2,369,769
COST OF REVENUE	(2,014,568)	(2,002,961)
GROSS PROFIT	364,118	366,808
OTHER INCOME	163,153	116,218
General and administrative	(415,629)	(383,177)
(LOSS)/PROFIT FROM OPERATIONS	111,642	99,849
FINANCE COSTS	(2,687)	(1,779)
(LOSS)/PROFIT BEFORE TAX	108,955	98,070
Tax expense	(20,068)	(15,990)
NET (LOSS)/PROFIT	88,887	82,080
GROSS PROFIT	364,118	366,808
NET LOSS	88,887	82,080
BGLC [Member]
REVENUE	0	0
COST OF REVENUE	0	0
GROSS PROFIT	0	0
OTHER INCOME	0	0
General and administrative	(149,422)	(107,440)
(LOSS)/PROFIT FROM OPERATIONS	(149,422)	(107,440)
FINANCE COSTS	(24)	0
(LOSS)/PROFIT BEFORE TAX	(149,446)	(107,440)
NET (LOSS)/PROFIT	(149,446)	(107,440)
GROSS PROFIT	0	0
NET LOSS	(149,446)	(107,440)
Income tax	$ 0	$ 0